Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Chromosomal autonomy of hMLH1 methylation in colon cancer

Abstract

Silencing of hMLH1 expression by aberrant hMLH1 promoter methylation accounts for the majority of sporadic colon cancers with microsatellite instability. We have previously shown hMLH1 silencing is biallelic and actively maintained. To study the mechanism of aberrant hMLH1 methylation, we assayed whether an hMLH1 methylated cell could transfer methylation and silencing to an exogenous hMLH1 promoter in somatic cell hybrids between hMLH1 methylated-silenced and hMLH1 unmethylated-expressing colon cancer cells. Conversely, we assayed whether these hybrids could reactivate expression of initially methylated and silenced hMLH1 alleles. Compellingly, within the hybrids each hMLH1 allele remained unchanged, retaining the expression status of its parental cell of origin. This chromosomal autonomy may not be simply determined by DNA methylation, as it is reasserted after experimentally forced demethylation of all hMLH1 alleles in the hybrids. Confirming findings included hMLH1 methylated cells being unable to methylate single transferred exogenous hMLH1 expressing chromosomes or transfected hMLH1 reporter constructs. hMLH1 silencing does not conform to either a dominant or recessive model, and is not determined by trans-acting factors differing between hMLH1 expressing or silenced genomes. We posit that hMLH1 methylation is dependent on and maintained by cis chromosomal marks, whose nature remains to be elucidated.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  • Arad U . 1998 Biotechniques 24: 760–762

  • Baylin SB, Herman JG, Graff JR, Vertino PM, Issa JP . 1998 Adv. Cancer Res. 72: 141–196

  • Casey G, Plummer S, Hoeltge G, Scanlon D, Fasching C, Standbridge EJ . 1993 Hum. Mol. Genet. 2: 1921–1927

  • Cheng Y, Poulos NE, Lung ML, Hampton G, Ou B, Lerman MI, Standbridge EJ . 1998 Proc. Natl. Acad. Sci. USA 95: 3042–3047

  • Deng G, Chen A, Hong J, Chae HS, Kim YS . 1999 Cancer Res. 59: 2029–2033

  • Eshleman JR, Markowitz SD . 1996 Hum. Mol. Genet. 5: 1489–1494

  • Geiser AG, Anderson MJ, Stanbridge EJ . 1989 Cancer Res. 49: 1572–1577

  • Grady WM, Rajput A, Lutterbaugh JD, Markowitz SD . 2001 Cancer Res. 61: 900–902

  • Grady WM, Willis J, Guilford PJ, Dunbier AK, Toro TT, Lynch H, Wiesner G, Ferguson K, Eng C, Park JG, Kim SJ, Markowitz S . 2000 Nat. Genet. 26: 16–17

  • Hark AT, Schoenherr CJ, Katz DJ, Ingram RS, Levorse JM, Tilghman SM . 2000 Nature 405: 486–489

  • Herman JG, Umar A, Polyak K, Graff JR, Ahuja N, Issa JP, Markowitz S, Willson JK, Hamilton SR, Kinzler KW, Kane MF, Kolodner RD, Vogelstein B, Kunkel TA, Baylin SB . 1998 Proc. Natl. Acad. Sci. USA 95: 6870–6875

  • Hsieh CL . 2000 Curr. Opin. Genet. Dev. 10: 224–228

  • Issa J . 2000 Ann. NY. Acad. Sci. 910: 140–153 discussion 153–155

  • Ito E, Yanagisawa Y, Iwahashi Y, Suzuki Y, Nagasaki H, Akiyama Y, Sugano S, Yuasa Y, Maruyama K . 1999 Biochem. Biophys. Res. Comm. 256: 488–494

  • Jacobsen SE, Meyerowitz EM . 1997 Science 277: 1100–1103

  • Jeddeloh JA, Stokes TL, Richards EJ . 1999 Nat. Genet. 22: 94–97

  • Kane MF, Loda M, Gaida GM, Lipman J, Mishra R, Goldman H, Jessup JM, Kolodner R . 1997 Cancer Res. 57: 808–811

  • Kuismanen SA, Holmberg MT, Salovaara R, de la Chapelle A, Peltomaki P . 2000 Am. J. Pathol. 156: 1773–1779

  • Kuzmin I, Geil L, Ge H, Bengtsson U, Duh FM, Stanbridge EJ, Lerman MI . 1999 Oncogene 18: 5672–5679

  • Lee YW, Klein CB, Kargacin B, Salnikow K, Kitahara J, Dowjat K, Zhitkovich A, Christie NT, Costa M . 1995 Mol. Cell. Biol. 15: 2547–2557

  • Markowitz S, Wang J, Myeroff L, Parsons R, Sun L, Lutterbaugh J, Fan RS, Zborowska E, Kinzler KW, Vogelstein B . et al 1995 Science 268: 1336–1338

  • Papadopoulos N, Nicolaides NC, Wei YF, Ruben SM, Carter KC, Rosen CA, Haseltine WA, Fleischmann RD, Fraser CM, Adams MD . et al 1994 Science 263: 1625–1629

  • Robertson KD, Junes PA . 2000 Carcinogenesis 21: 461–467

  • Veigl ML, Kasturi L, Olechnowicz J, Ma AH, Lutterbaugh JD, Periyasamy S, Li GM, Drummond J, Modrich PL, Sedwick WD, Markowitz SD . 1998 Proc. Natl. Acad. Sci. USA 95: 8698–8702

  • Wiesner GL, Platzer P, Buxbaum S, Lewis S, MacMillen M, Olechnowicz J, Willis J, Chakravarti A, Elston RC, Markowitz SD . 2001 J. Natl. Cancer Inst. 93: 635–639

  • Willson JK, Bittner GN, Oberley TD, Meisner LF, Weese JL . 1987 Cancer Res. 47: 2704–2713

Download references

Acknowledgements

We thank Song Song for her technical assistance. The work is supported by PHS grants RO1 CA67409, RO1 CA72160 and P30 CA43703, and by gifts from the National Colon Cancer Research Alliance. S Markowitz is an associate investigator of the Howard Hughes Medical Institute.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sanford Markowitz.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Li, H., Myeroff, L., Kasturi, L. et al. Chromosomal autonomy of hMLH1 methylation in colon cancer. Oncogene 21, 1443–1449 (2002). https://doi.org/10.1038/sj.onc.1205247

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205247

Keywords

This article is cited by

Search

Quick links